Filing Details

Accession Number:
0001209191-14-041406
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-13 18:31:41
Reporting Period:
2014-06-06
Filing Date:
2014-06-13
Accepted Time:
2014-06-13 18:31:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569926 P. Sean Nolan 3280 Bayshore Blvd
Brisbane CA 94005
Evp & Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-06 10,000 $9.29 75,671 No 4 M Direct
Common Stock Disposition 2014-06-06 10,000 $41.25 65,671 No 4 S Direct
Common Stock Acquisiton 2014-06-13 10,000 $9.29 75,671 No 4 M Direct
Common Stock Disposition 2014-06-13 10,000 $44.35 65,671 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock options (right to buy) Disposition 2014-06-06 10,000 $0.00 10,000 $9.29
Common Stock Stock options (right to buy) Disposition 2014-06-13 10,000 $0.00 10,000 $9.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
178,000 2020-03-07 No 4 D Direct
168,000 2020-03-07 No 4 D Direct
Footnotes
  1. The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
  2. Fully exercisable.